We are live on ! Find out more
ARTA

A.R.T. Advisors Portfolio holdings

AUM $1.79M
1-Year Est. Return 57.47%
This Fund
S&P 500
This Quarter Est. Return
-1.4%
1 Year Est. Return
+57.47%
3 Year Est. Return
+81.79%
5 Year Est. Return
+178.88%
10 Year Est. Return
–
AUM
$2B
AUM Growth
+$231M
Cap. Flow
+$286M
Cap. Flow %
14.32%
Top 10 Hldgs %
8.34%
Holding
1,933
New
619
Increased
448
Reduced
311
Closed
543

Top Buys

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$17.8M
2
INTC icon
Intel
INTC
+$17.4M
3
EOG icon
EOG Resources
EOG
+$12.8M
4
AMZN icon
Amazon
AMZN
+$11.9M
5
NVDA icon
NVIDIA
NVDA
+$10.4M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$25M
2
HLF icon
Herbalife
HLF
+$20.8M
3
HD icon
Home Depot
HD
+$12.7M
4
BKNG icon
Booking.com
BKNG
+$12M
5
CMG icon
Chipotle Mexican Grill
CMG
+$11.6M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.88%
2 Technology 15.21%
3 Financials 12.06%
4 Industrials 12.01%
5 Healthcare 11.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VLRX
1326
DELISTED
VALERITAS HOLDINGS INC
VLRX
$45K ﹤0.01%
+31,559
New +$73.2K
CLDX icon
1327
Celldex Therapeutics
CLDX
$2.94B
$42K ﹤0.01%
19,741
-33,000
-63% -$76.4K
MDWD icon
1328
MediWound
MDWD
$184M
$42K ﹤0.01%
+1,894
New +$42.1K
CALA
1329
DELISTED
Calithera Biosciences, Inc
CALA
$42K ﹤0.01%
+677
New +$54.2K
APVO icon
1330
Aptevo Therapeutics
APVO
$4.96M
– –
0
– –
PSTV icon
1331
Plus Therapeutics
PSTV
$25M
$41K ﹤0.01%
+32
New +$116K
GRCE
1332
Grace Therapeutics
GRCE
$33.8M
$41K ﹤0.01%
+450
New +$41.7K
MMAT
1333
DELISTED
Meta Materials Inc. Common Stock
MMAT
$41K ﹤0.01%
+174
New +$46.1K
AUD
1334
DELISTED
Audacy, Inc.
AUD
$41K ﹤0.01%
12,345
-103,900
-89% -$466K
GSV
1335
DELISTED
Gold Standard Ventures Corp.
GSV
$40K ﹤0.01%
+52,213
New +$50.6K
CHAP
1336
DELISTED
Chaparral Energy, Inc.
CHAP
$40K ﹤0.01%
+29,641
New +$81.9K
TWI icon
1337
Titan International
TWI
$492M
$39K ﹤0.01%
14,559
-21,200
-59% -$69.8K
VHI icon
1338
Valhi
VHI
$389M
$39K ﹤0.01%
+1,707
New +$43.6K
AKTX
1339
Akari Therapeutics
AKTX
$14.4M
$36K ﹤0.01%
+27
New +$41.3K
INDP icon
1340
Indaptus Therapeutics
INDP
$243M
$35K ﹤0.01%
+21
New +$62.5K
HYRE
1341
DELISTED
HyreCar Inc. Common Stock
HYRE
$35K ﹤0.01%
+13,914
New +$43.4K
NEOS
1342
DELISTED
Neos Therapeutics, Inc
NEOS
$35K ﹤0.01%
+23,524
New +$38.1K
IFRX icon
1343
InflaRx
IFRX
$243M
$34K ﹤0.01%
13,790
-15,372
-53% -$44.7K
ABUS icon
1344
Arbutus Biopharma
ABUS
$847M
$33K ﹤0.01%
21,674
-13,775
-39% -$23.7K
ACHV icon
1345
Achieve Life Sciences
ACHV
$633M
$32K ﹤0.01%
+934
New +$36.7K
EVOK
1346
DELISTED
Evoke Pharma
EVOK
$32K ﹤0.01%
+257
New +$34.4K
NUWE icon
1347
Nuwellis
NUWE
$174K
– –
0
– –
STKL
1348
DELISTED
SunOpta
STKL
$32K ﹤0.01%
17,657
-45,631
-72% -$118K
SUNW
1349
DELISTED
Sunworks, Inc.
SUNW
$32K ﹤0.01%
+13,500
New +$43.7K
MBRX icon
1350
Moleculin Biotech
MBRX
$9.61M
$31K ﹤0.01%
+13
New +$33.6K
52 53
54
55 56

Similar funds

MA
MANA Advisors New York $3.06M AUM 7.13% 1-Year Est. Return
FFIM
Founders Fund III Management San Francisco, California $435K AUM
LC
Lunia Capital Dallas, Texas $4.49M AUM 42.82% 1-Year Est. Return
YEPV
Yorktown Energy Partners VI New York $6.21M AUM 74.4% 1-Year Est. Return
AAM
Areion Asset Management Hong Kong $7.82M AUM 16% 1-Year Est. Return
CCM
Copernicus Capital Management San Francisco, California $8.26M AUM 37.91% 1-Year Est. Return
IR
Invictus RG Hamilton, Bermuda $8.9M AUM 56.32% 1-Year Est. Return
IFC
Intact Financial Corporation Toronto, Ontario, Canada $14M AUM

A.R.T. Advisors's Q3 2019 Portfolio in Review

As of Q3 2019, A.R.T. Advisors held 1,933 positions worth $2B, up 13% from $1.77B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.

A.R.T. Advisors deployed $286M of net new capital in Q3 2019, opening 619 new positions and adding to 448 existing holdings. Its largest new stake was Netflix: 570,000 shares worth $15.3M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, down from 23% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Booking.com, an estimated $12M trimmed.

  • A.R.T. Advisors's largest Q3 2019 buy was Netflix: 570,000 shares worth $15.3M.
  • A.R.T. Advisors added most to Intel in Q3 2019, an estimated $17.4M increase.
  • A.R.T. Advisors's biggest Q3 2019 reduction was Booking.com, cutting an estimated $12M.
  • A.R.T. Advisors fully exited Apple in Q3 2019, selling an estimated $25M.
  • A.R.T. Advisors's ten largest holdings make up 8.3% of its $2B portfolio in Q3 2019.
  • A.R.T. Advisors opened 619 new positions and closed 543 in Q3 2019.
  • A.R.T. Advisors's portfolio value rose 13% quarter-over-quarter to $2B.

Based on A.R.T. Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.